The Plasma Proteins Market in Europe — 2020
The report entitled The Plasma Proteins Market in the Europe 2020 provides sales in units and dollars of all the therapeutic plasma and recombinant proteins by company for 38 total countries. It covers complete historical sales of 2020 and some events in early 2021 and was completed in the beginning of 2022. These countries included are:
Austria, Balkans (Albania, Bosnia-Herzegovina, Croatia, Kosovo, Montenegro, North Macedonia, Serbia and Slovenia) and Baltics (Estonia, Latvia, Lithuania), Belarus, Belgium, Bulgaria, Czechia, Denmark, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Ireland, Italy, Kazakhstan, Netherlands, Norway, Poland, Portugal, Romania, Russia, Slovakia, Spain, Sweden, Switzerland, Ukraine, United Kingdom and Uzbekistan.
This report is updated every three years and has historical data from 2011, 2014 and 2017 for analyzing recent growth trajectories.
As in previous reports, the sales data in this region reflect the results of public tenders, and sales of the smaller, but growing private markets. The report also analyses products distribution and pricing, blood and plasma collections, plasma fractionation, hemophilia care and new product introductions.
The report is delivered electronically (Excel and pdf files). Each country chapter covers the topics listed in the table of contents of a sample country chapter below.
For more information or to order this report, please contact
Marketing Research Bureau at firstname.lastname@example.org, or +1 425 502 6265.
THE PLASMA PROTEINS MARKET IN THE EUROPE – 2020
TABLE OF CONTENTS OF A SAMPLE COUNTRY CHAPTER
HEALTH CARE ENVIRONMENT
BLOOD AND PLASMA COLLECTIONS
INTRAMUSCULAR IMMUNE GLOBULIN MARKET
Polyvalent Intramuscular & Subcutaneous Immune Globulin
Tetanus Immune Globulin
Rho(D) Immune Globulin
Rabies immune Globulin
Hepatitis B Immune Globulin
Other Hyperimmune Globulin
IVIG & SCIG MARKET
HEMOPHILIA CARE MARKET
Demographic Data on Hemophilia
Hemophilia Care Delivery
Hemophilia A/Factor VIII (Plasma derived, recombinant and non-factors (Hemlibra)
Factor IX (Plasma derived and recombinant products)
von Willebrand Factor
Inhibitor Care Market
OTHER PLASMA PRODUCTS MARKETS
REGISTRATION AND REGULATIONS
PRICING AND DISTRIBUTION
MARKET TRENDS AND THREE YEAR FORECAST
LIST OF MAJOR COMPANIES AND ORGANIZATIONS